← Open Payments lookup

NADIASLY SANTILLANO CUESTA: Open Payments

NPI 1134595259 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 14 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $697 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$142
ABBVIE INC.2$57
Exact Sciences Corporation2$46
Amgen Inc.1$22
Novo Nordisk Inc1$18
Astellas Pharma US Inc1$17
Dexcom, Inc.1$14

Products named: FARXIGA, Cologuard Collection Kit, CREON, FASENRA, QULIPTA, Repatha, Veozah, Dexcom G6 Transmitter.

Industry payments across NV — which companies pay providers there.